Piper Sandler Lowers Veeva Systems (NYSE:VEEV) Price Target to $285.00

Veeva Systems (NYSE:VEEVGet Free Report) had its price target lowered by research analysts at Piper Sandler from $355.00 to $285.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the technology company’s stock. Piper Sandler’s price objective points to a potential upside of 45.49% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the stock. Morgan Stanley upped their price target on shares of Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a research note on Thursday. Robert W. Baird raised their price objective on shares of Veeva Systems from $314.00 to $319.00 and gave the company an “outperform” rating in a research note on Friday, November 21st. Weiss Ratings cut shares of Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Oppenheimer dropped their target price on shares of Veeva Systems from $325.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company cut their price target on shares of Veeva Systems from $341.00 to $333.00 and set an “overweight” rating on the stock in a report on Tuesday, November 25th. Seventeen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $284.91.

View Our Latest Stock Report on VEEV

Veeva Systems Trading Down 0.1%

Shares of NYSE:VEEV opened at $195.89 on Thursday. The stock has a fifty day simple moving average of $203.47 and a two-hundred day simple moving average of $247.42. The stock has a market capitalization of $32.20 billion, a price-to-earnings ratio of 36.21, a PEG ratio of 1.35 and a beta of 1.09. Veeva Systems has a 12-month low of $168.13 and a 12-month high of $310.50.

Veeva Systems (NYSE:VEEVGet Free Report) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The business had revenue of $835.95 million for the quarter, compared to the consensus estimate of $810.95 million. During the same period in the previous year, the company posted $1.74 earnings per share. The company’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, equities research analysts predict that Veeva Systems will post 4.35 EPS for the current year.

Veeva Systems announced that its board has approved a stock repurchase program on Monday, January 5th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the technology company to purchase up to 5.5% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the business’s stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total value of $231,430.00. Following the completion of the transaction, the insider owned 23,204 shares of the company’s stock, valued at approximately $5,370,101.72. The trade was a 4.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 10.30% of the company’s stock.

Institutional Trading of Veeva Systems

A number of institutional investors have recently made changes to their positions in VEEV. Vanguard Group Inc. grew its stake in shares of Veeva Systems by 3.1% in the third quarter. Vanguard Group Inc. now owns 15,429,231 shares of the technology company’s stock worth $4,596,522,000 after acquiring an additional 457,806 shares during the period. Alliancebernstein L.P. lifted its position in Veeva Systems by 4.1% during the third quarter. Alliancebernstein L.P. now owns 5,941,631 shares of the technology company’s stock valued at $1,770,071,000 after purchasing an additional 235,983 shares during the period. Principal Financial Group Inc. lifted its position in Veeva Systems by 0.6% during the fourth quarter. Principal Financial Group Inc. now owns 3,870,293 shares of the technology company’s stock valued at $863,978,000 after purchasing an additional 23,416 shares during the period. State Street Corp boosted its holdings in Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company’s stock worth $801,267,000 after purchasing an additional 85,695 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Veeva Systems by 4.8% in the third quarter. JPMorgan Chase & Co. now owns 3,476,258 shares of the technology company’s stock worth $1,035,622,000 after purchasing an additional 159,984 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

  • Positive Sentiment: Q4 beats and raised outlook — Veeva reported revenue of ~$836M (+16% y/y) and non‑GAAP EPS of $2.06, above consensus, and provided FY27 guidance that came in ahead of some estimates, which drove the initial rally. Article Title
  • Positive Sentiment: AI and product roadmap cited as growth drivers — Management emphasized “agentic” AI initiatives and CRM expansion (CRM targeted to be ~10% of revenue by 2030), positioning Veeva to capture higher‑value services and offset broader software AI fears. Article Title
  • Positive Sentiment: Analyst support and buy ratings remain — Several firms reaffirmed or raised ratings/targets (e.g., Stifel raised target to $245; Truist reaffirmed buy), keeping institutional sentiment constructive despite some cuts. Article Title
  • Neutral Sentiment: Earnings call detail available for deeper read — The full Q4 earnings call/transcript provides color on customer uptake, AI timing and margin outlook; useful for investors who want to judge execution risk vs opportunity. Article Title
  • Neutral Sentiment: Technical/volume context — Trading volume was a bit below average and the stock remains under its 50‑ and 200‑day moving averages, which can limit near‑term upside until momentum recovers. (See market data summary above.)
  • Negative Sentiment: Price‑target cuts and cautious notes — Multiple firms trimmed price targets (Canaccord, Piper Sandler, Needham, RBC, Wells Fargo among others) citing decelerating growth, margin pressure or to reflect model changes—these headlines trimmed upside and likely capped the post‑earnings rally. Article Title
  • Negative Sentiment: Ongoing AI disruption debate — Despite Veeva’s positioning, some investors remain worried about how AI will change software economics and competitive dynamics; a few analysts argue AI risk and growth normalization justify a more cautious stance. Article Title

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Recommended Stories

Analyst Recommendations for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.